HRT Financial’s Indaptus Therapeutics INDP Stock Holding History

HRT Financial’s Portfolio INDP Stock Details INDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$618K	Buy	+206,077	New	+$519K	﹤0.01%	2494
2019 Q4	–	Sell	-13	Closed	-$21K	–	1383
2019 Q3	$21K	Buy	+13	New	+$38.7K	﹤0.01%	1337

Other funds holding INDP

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

HRT Financial's INDP Position: Q2 2026 in Review

HRT Financial opened a new position in Indaptus Therapeutics (INDP) in Q2 2026: 206,077 shares worth $618K. The stake represents ﹤0.01% of the portfolio and ranks #2494 among its holdings. This is a return to the name: HRT Financial previously reported a position in INDP as recently as Q3 2019.

HRT Financial first reported a position in INDP in Q3 2019 and has held it in 2 quarters since. 9 funds tracked by Wall St. Rank hold INDP as of Q2 2026.

HRT Financial held 206,077 shares of Indaptus Therapeutics worth $618K as of Q2 2026.
Indaptus Therapeutics was a new HRT Financial position in Q2 2026.
Indaptus Therapeutics made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #2494 holding.
HRT Financial first reported a position in Indaptus Therapeutics in Q3 2019 and has held it in 2 quarters since.
9 funds tracked by Wall St. Rank held Indaptus Therapeutics as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.